| 000 | 01723 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516033910.0 | ||
| 264 | 0 | _c20110624 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0b013e318218107a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrupp, L B | |
| 245 | 0 | 0 |
_aMulticenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. _h[electronic resource] |
| 260 |
_bNeurology _cApr 2011 |
||
| 300 |
_a1500-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aDonepezil |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndans _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMemory Disorders _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xcomplications |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVerbal Learning _xdrug effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aChristodoulou, C | |
| 700 | 1 | _aMelville, P | |
| 700 | 1 | _aScherl, W F | |
| 700 | 1 | _aPai, L-Y | |
| 700 | 1 | _aMuenz, L R | |
| 700 | 1 | _aHe, D | |
| 700 | 1 | _aBenedict, R H B | |
| 700 | 1 | _aGoodman, A | |
| 700 | 1 | _aRizvi, S | |
| 700 | 1 | _aSchwid, S R | |
| 700 | 1 | _aWeinstock-Guttman, B | |
| 700 | 1 | _aWestervelt, H J | |
| 700 | 1 | _aWishart, H | |
| 773 | 0 |
_tNeurology _gvol. 76 _gno. 17 _gp. 1500-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e318218107a _zAvailable from publisher's website |
| 999 |
_c20784001 _d20784001 |
||